“…In model 1, data were adjusted for demographic, socioeconomic and lifestyle factors, including age, sex, race/ethnicity, education, smoking, pack-years of smoking, current alcohol use and physical activity. In model 2, data were further adjusted for established CVD risk, including BMI, diabetes, hypertension, HOMA-IR, high-density lipoprotein (HDL) cholesterol, triglycerides, eGFR, and use of lipid-lowering medication, which have been found to correlate with FGF21 levels in previous studies 5,9,10,13,14 . As FGF21 has anti-inflammatory effects 8 and pericardial fat can secrete pro-inflammatory cytokines 1 , data were further adjusted for circulating inflammatory biomarkers, including CRP and IL-6 in model 3, in order to assess whether these inflammatory biomarkers can mediate the association.…”